Hinge Health is trading 4.22% up at $96.60 after completing its $105 million Cylinder Health acquisition.
- The transaction expands Hinge Health into gastrointestinal care, with its integrated GI Care Program expected to launch in 2027.
- The acquisition follows strong second-quarter results and raised 2026 guidance.
- No separate September 9 earnings release or analyst action was identified; the acquisition appears to be the clearest company-specific catalyst.